{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:48:46Z","timestamp":1785916126311,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ayurveda and Integrative Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaim.2026.101366","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:00:52Z","timestamp":1784908852000},"page":"101366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an \u03b1-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0662-4837","authenticated-orcid":false,"given":"Rajamanickam","family":"Baskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8459-3274","authenticated-orcid":false,"given":"Manoharan","family":"Harini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6101-8623","authenticated-orcid":false,"given":"Sikkal Selvaraaju","family":"Selvapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5771-759X","authenticated-orcid":false,"given":"Thangarasu","family":"Hemadevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2216-3153","authenticated-orcid":false,"given":"Arumugam","family":"Rajalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-9399","authenticated-orcid":false,"given":"Kuppuswamy","family":"Kavitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-5653","authenticated-orcid":false,"given":"Rengarajulu","family":"Puvanakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-3178","authenticated-orcid":false,"given":"Balasubramanian","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaim.2026.101366_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jaim.2026.101366_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216514","article-title":"Natural inhibitors of mammalian \u03b1-amylases as promising drugs for the treatment of metabolic diseases","volume":"24","author":"Kalinovskii","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaim.2026.101366_bib3","doi-asserted-by":"crossref","DOI":"10.2174\/0115733998304373240611110224","article-title":"Molecular mechanisms underlying the therapeutic potential of plant-based \u03b1-amylase inhibitors for hyperglycemic control in diabetes","volume":"21","author":"Kaur","year":"2025","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jaim.2026.101366_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12906-016-1085-1","article-title":"In vitro and in vivo \u03b1-amylase and \u03b1-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.)","volume":"16","author":"Poovitha","year":"2016","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.jaim.2026.101366_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/17568919.2025.2453421","article-title":"Key molecular scaffolds in the development of clinically viable \u03b1-amylase inhibitors","volume":"17","author":"Singh","year":"2025","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib6","article-title":"Metformin toxicity leading to severe refractory hyperkalemia and metabolic acidosis: a case report","volume":"16","author":"Wagle","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jaim.2026.101366_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.975912","article-title":"Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review, meta-analysis and meta-regression of randomized controlled trials","volume":"13","author":"Nabrdalik","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jaim.2026.101366_bib8","article-title":"Metformin-induced chronic diarrhea misdiagnosed as irritable bowel syndrome for years","volume":"16","author":"Chaudhary","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jaim.2026.101366_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/ph17070898","article-title":"Metformin-associated gastrointestinal adverse events are reduced by probiotics: a meta-analysis","volume":"17","author":"Pajor","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jaim.2026.101366_bib10","first-page":"52","article-title":"Reducing or discontinuing insulin or sulfonylurea when initiating a glucagon-like peptide-1 agonist","volume":"41","author":"Herron","year":"2024","journal-title":"Fed Pract"},{"key":"10.1016\/j.jaim.2026.101366_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/cpt.2570","article-title":"Sulfonylureas and the risk of ventricular arrhythmias among people with type 2 diabetes: a systematic review of observational studies","volume":"111","author":"Islam","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaim.2026.101366_bib12","article-title":"Glycemic levels and cardiovascular events in type 2 diabetes: a cohort study of drugs with different hypoglycemic potentials","volume":"15","author":"Lin","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaim.2026.101366_bib13","series-title":"Nutritional and therapeutic interventions for diabetes and metabolic syndrome","first-page":"455","article-title":"Current antidiabetic drugs: review of their efficacy and safety","author":"Hossain","year":"2018"},{"key":"10.1016\/j.jaim.2026.101366_bib14","first-page":"117","article-title":"An insight of alpha-amylase inhibitors as a valuable tool in the management of type 2 diabetes mellitus","volume":"16","author":"Bashary","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jaim.2026.101366_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/biom10030452","article-title":"Green synthesis of gold nanoparticles capped with procyanidins from Leucosidea sericea as potential antidiabetic and antioxidant agents","volume":"10","author":"Badeggi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaim.2026.101366_bib16","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s13300-020-00922-x","article-title":"Pharmacogenomic studies of current antidiabetic agents and potential new drug targets for precision medicine of diabetes","volume":"11","author":"Zeng","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jaim.2026.101366_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10799893.2020.1800734","article-title":"In silico assessment of potential leads identified from Bauhinia rufescens Lam. as \u03b1-glucosidase and \u03b1-amylase inhibitors","volume":"41","author":"Osman","year":"2021","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jaim.2026.101366_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/0113894501313365240722100902","article-title":"Recent advances in the development of alpha-glucosidase and alpha-amylase inhibitors in type 2 diabetes management: insights from in silico to in vitro studies","volume":"25","author":"Khan","year":"2024","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaim.2026.101366_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/2589977515666230217114449","article-title":"Herbal approach for diabetic cure and futuristic dimension","volume":"15","author":"Singh","year":"2023","journal-title":"Curr Drug Res Rev"},{"key":"10.1016\/j.jaim.2026.101366_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00709-025-02056-y","article-title":"Acute and chronic toxicity study for Madhumukthi Kudineer Chooranum","volume":"262","author":"Baskar","year":"2025","journal-title":"Protoplasma"},{"key":"10.1016\/j.jaim.2026.101366_bib21","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaim.2026.101366_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.1865","article-title":"The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif","volume":"11","author":"Williams","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jaim.2026.101366_bib23","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jaim.2026.101366_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib25","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaim.2026.101366_bib26","series-title":"Discovery Studio Visualizer, 21.1.0.20298","year":"2020"},{"key":"10.1016\/j.jaim.2026.101366_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaim.2026.101366_bib28","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaim.2026.101366_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00894-023-05813-z","article-title":"Identification of apigenin-4\u2019-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies","volume":"30","author":"Harini","year":"2024","journal-title":"J Mol Model"},{"key":"10.1016\/j.jaim.2026.101366_bib30","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Tresanco","year":"2021","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.jaim.2026.101366_bib31","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.3390\/ijms26178170","article-title":"Exploring the anticancer potential of proton pump inhibitors by targeting GRP78 and V-ATPase: molecular docking, molecular dynamics, PCA, and MM-GBSA calculations","volume":"26","author":"Elfiky","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaim.2026.101366_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5001\/omj.2011.40","article-title":"In vitro \u03b1-amylase inhibition and antioxidant activities of methanolic extract of Amaranthus caudatus Linn","volume":"26","author":"Kumar","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.jaim.2026.101366_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2022.05.026","article-title":"Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET","volume":"347","author":"Garcia-Varela","year":"2022","journal-title":"J Contr Release"},{"key":"10.1016\/j.jaim.2026.101366_bib34","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.1021\/acs.jmedchem.3c00107","article-title":"Inclusion of control data in fits to concentration-response curves improves estimates of half-maximal concentrations","volume":"66","author":"La","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jaim.2026.101366_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery","volume":"1","author":"Ghose","year":"1999","journal-title":"J Comb Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib38","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular Properties that influence the oral bioavailability of Drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib39","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib40","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib41","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s11030-023-10728-1","article-title":"An insight on medicinal attributes of 1,2,3\u2010 and 1,2,4\u2010triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors","volume":"28","author":"Sharma","year":"2024","journal-title":"Mol Divers"},{"key":"10.1016\/j.jaim.2026.101366_bib42","first-page":"1632","article-title":"Novel oxadiazole derivatives as potent inhibitors of \u03b1-amylase and \u03b1-glucosidase enzymes: synthesis, in vitro evaluation, and molecular docking studies","volume":"24","author":"Bukhari","year":"2021","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.jaim.2026.101366_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4155\/fmc-2022-0317","article-title":"Synthetic piperidine-substituted chalcones as potential hits for \u03b1-amylase inhibitory and antioxidant activities","volume":"15","author":"Haq","year":"2023","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11030-019-09925-8","article-title":"Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro \u03b1-glucosidase inhibition, kinetic and docking studies","volume":"24","author":"Peytam","year":"2020","journal-title":"Mol Divers"},{"key":"10.1016\/j.jaim.2026.101366_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404127","article-title":"Enzymolysis modes trigger diversity in inhibitor\u2010\u03b1\u2010amylase aggregating behaviors and activity inhibition: a new insight into enzyme inhibition","volume":"11","author":"Cao","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.jaim.2026.101366_bib46","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jprot.2012.01.041","article-title":"Amino acids: chemistry, functionality and selected non-enzymatic post-translational modifications","volume":"75","author":"Bischoff","year":"2012","journal-title":"J Proteonomics"},{"key":"10.1016\/j.jaim.2026.101366_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/1573406415666181217114101","article-title":"Inhibition of \u03b1-amylase activity by Zn2+: insights from spectroscopy and molecular dynamics simulations","volume":"15","author":"Siming","year":"2019","journal-title":"Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib48","series-title":"Docking screens for drug discovery. Methods in molecular biology","first-page":"79","article-title":"Van der Waals potential in protein complexes","author":"Bitencourt-Ferreira","year":"2019"},{"key":"10.1016\/j.jaim.2026.101366_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmr.2332","article-title":"Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs","volume":"27","author":"Gallina","year":"2014","journal-title":"J Mol Recogn"},{"key":"10.1016\/j.jaim.2026.101366_bib50","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00894-014-2136-5","article-title":"C-H\u2026pi interactions in proteins: prevalence, pattern of occurrence, residue propensities, location, and contribution to protein stability","volume":"20","author":"Kumar","year":"2014","journal-title":"J Mol Model"},{"key":"10.1016\/j.jaim.2026.101366_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-0716-0282-9_5","article-title":"Underappreciated chemical interactions in protein-ligand complexes","volume":"2114","author":"Anighoro","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaim.2026.101366_bib52","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1021\/acs.jmedchem.2c01824","article-title":"Explaining blood-brain barrier permeability of small molecules by integrated analysis of different transport mechanisms","volume":"66","author":"Cornelissen","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/cmb.2017.0149","article-title":"Prediction of central nervous system side effects through drug permeability to blood-brain barrier and recommendation algorithm","volume":"25","author":"Fan","year":"2018","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jaim.2026.101366_bib54","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2174\/1389557520666200619121003","article-title":"Structure-activity relationships of natural and synthetic indole-derived scaffolds as \u03b1-glucosidase inhibitors: a mini-review","volume":"20","author":"Wang","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106478","article-title":"1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 main protease inhibitors: in silico screening and molecular dynamics simulation of potential COVID-19 drug candidates","volume":"267","author":"Kavitha","year":"2020","journal-title":"Biophys Chem"},{"key":"10.1016\/j.jaim.2026.101366_bib56","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1021\/acs.jpcb.3c04366","article-title":"Riding the wave: unveiling the conformational waves from RBD of SARS-CoV-2 spike protein to ACE2","volume":"127","author":"Maroli","year":"2023","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jaim.2026.101366_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sajb.2024.01.061","article-title":"Identification of alpha-glucosidase enzyme inhibitors from phytochemicals via integrated deep learning, molecular docking, molecular dynamics simulation, and MMPBSA analysis","volume":"167","author":"Sharma","year":"2024","journal-title":"South Afr J Bot"},{"key":"10.1016\/j.jaim.2026.101366_bib58","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1021\/acs.jcim.3c00105","article-title":"Elucidating atomistic insight into the dynamical responses of the sars-cov-2 main protease for the binding of remdesivir analogues: leveraging molecular mechanics to decode the inhibition mechanism","volume":"63","author":"Samanta","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jaim.2026.101366_bib59","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1080\/07391102.2020.1801507","article-title":"Molecular dynamics simulation for screening phytochemicals as \u03b1-amylase inhibitors from medicinal plants","volume":"39","author":"Sharma","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jaim.2026.101366_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112240","article-title":"The medicinal properties of Cassia fistula L: a review","volume":"144","author":"Mwangi","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaim.2026.101366_bib61","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.3390\/molecules27175590","article-title":"Phenolic profile, antioxidant and enzyme inhibitory activities of leaves from two Cassia and two Senna species","volume":"27","author":"Omer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jaim.2026.101366_bib62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1753-0407.13163","article-title":"Inhibition of \u03b1-glucosidase and \u03b1-amylase by herbal compounds for the treatment of type 2 diabetes: a validation of in silico reverse docking with in vitro enzyme assays","volume":"13","author":"Tolmie","year":"2021","journal-title":"J Diabetes"},{"key":"10.1016\/j.jaim.2026.101366_bib63","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/ptr.6954","article-title":"The genus Cassia L.: ethnopharmacological and phytochemical overview","volume":"35","author":"Khurm","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaim.2026.101366_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ayu.AYU_45_15","article-title":"Clinical evaluation of Triv\u1e5bta powder (Operculina turpethum Linn.) and Aragvadha Patra Lepa (paste of leaves of Cassia fistula Linn.) in the management of Vicharchika (eczema)","volume":"39","author":"Talekar","year":"2018","journal-title":"Ayu"},{"key":"10.1016\/j.jaim.2026.101366_bib65","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s12325-020-01602-9","article-title":"The effects of Acarbose on non-diabetic overweight and obese patients: a meta-analysis","volume":"38","author":"Yu","year":"2021","journal-title":"Adv Ther"}],"container-title":["Journal of Ayurveda and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947626000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947626000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:15:11Z","timestamp":1785914111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975947626000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0975947626000501"],"URL":"https:\/\/doi.org\/10.1016\/j.jaim.2026.101366","relation":{},"ISSN":["0975-9476"],"issn-type":[{"value":"0975-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidiabetic potential of a novel hydroxyphenyl-bi-benzopyran-hexol compound from Cassia fistula as an \u03b1-amylase inhibitor: Integrated in silico screening and in vitro validation using a nonlinear regression model","name":"articletitle","label":"Article Title"},{"value":"Journal of Ayurveda and Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaim.2026.101366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Science and Technology and World Ayurveda Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101366"}}